Experiment 405301

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBED

Compounds isolated

ABRIN

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationTUNG,TC: LIN,JY:. (1975). ANTICANCER COMPOSITION.. ()
Amount utilized
Compound isolated
DiseaseMIXED WITH RNA EFFECTIVE OF 7 OF 12 CASES PRIMARY CERVICAL CANCER EFFECTIVE IN 10 OF 17 CASES OF RECURRENT CERV CA
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
GenderFEMALE